Euparal essence , ready-to-use, for microscopy

Hazard statements (CLP)

H226, H315, H318, H335, H371

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture

Hazard categories

Cat- Hazard class and Hazard egory category statement 2.6 Flammable liquid Flam. Liq. 3 H226 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation Eye Dam. 1 H318 3.8 Specific target organ toxicity - single exposure STOT SE 2 H371 3.8R Specific target organ toxicity - single exposure (respir- STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16

Most important adverse effects

Immediate effects can be expected after short-term exposure. The product is combustible and can be ignited by potential ignition sources

Signal word

Danger Danger Not required

Hazard pictograms

GHS02, GHS05, GHS07, GHS08 H318 Causes serious eye damage. H335 May cause respiratory irritation. P261 Avoid breathing mist/vapours/spray. P280 Wear protective gloves/eye protection. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

Hazard statements

H226 Flammable liquid and vapour H315 Causes skin irritation H318 Causes serious eye damage H335 May cause respiratory irritation H371 May cause damage to organs Not required

Prevention

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking P261 Avoid breathing mist/vapours/spray P280 Wear protective gloves/eye protection

Response

P302+P352 IF ON SKIN: Wash with plenty of water P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337+P313 If eye irritation persists: Get medical advice/attention

Hazardous Ingredients

Camphor, Phenyl salicylate Labelling of packages where the contents do not exceed 125 ml

Contains

Camphor, Phenyl salicylate Labelling of packages where the contents do not exceed 10 ml

Precautionary statements

Not required

Results of PBT and vPvB assessment

Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 2.6 Flammable liquid 3 Flam. Liq. 3 H226 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 1 Eye Dam. 1 H318 3.8 Specific target organ toxicity - single exposure 2 STOT SE 2 H371 3.8R Specific target organ toxicity - single exposure (respir- 3 STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Immediate effects can be expected after short-term exposure. The product is combustible and can be ignited by potential ignition sources.